Chen, J.; Qiao, Y.; Qiao, G.; Jia, X.; Zhu, J.
Mining of Adverse Event Signals Associated with Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy: A Post-Marketing Analysis Based on FAERS. Pharmacy 2025, 13, 178.
https://doi.org/10.3390/pharmacy13060178
AMA Style
Chen J, Qiao Y, Qiao G, Jia X, Zhu J.
Mining of Adverse Event Signals Associated with Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy: A Post-Marketing Analysis Based on FAERS. Pharmacy. 2025; 13(6):178.
https://doi.org/10.3390/pharmacy13060178
Chicago/Turabian Style
Chen, Jiajun, Ying Qiao, Gaoxing Qiao, Xiaocan Jia, and Jicun Zhu.
2025. "Mining of Adverse Event Signals Associated with Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy: A Post-Marketing Analysis Based on FAERS" Pharmacy 13, no. 6: 178.
https://doi.org/10.3390/pharmacy13060178
APA Style
Chen, J., Qiao, Y., Qiao, G., Jia, X., & Zhu, J.
(2025). Mining of Adverse Event Signals Associated with Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy: A Post-Marketing Analysis Based on FAERS. Pharmacy, 13(6), 178.
https://doi.org/10.3390/pharmacy13060178